Medication info
Allermont Chewable Tablet 5 mg (Montelukast Sodium)

Allermont Chewable Tablet 5 mg (Montelukast Sodium)

Prescription medicationChewable TabletOral
Ingredient · strength
Montelukast Sodium›5.2mg / 1 tablet
Manufacturer / importer
Gujoo Pharmaceutical Co., Ltd.
Appearance
Pink chewable tablets with a biconvex round shape
Packaging
28 tablets (7 tablets/PTP×4)
Approval status
Active

MFDS item code 201405469 · Approved 2014.11.24 · Insurance code 669804500

Summary

Main use
Relief of allergic rhinitis symptoms; prevention and maintenance treatment of asthma
Who takes it
Adults · Children
Adult dose
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. 10 mg tablet Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily. 10 mg orally disintegrating film Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. ○ How to take the dry syrup (for syrup formulations only) To take, pour 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water and take the entire amount immediately (within 15 minutes). Do not leave this medicine suspended in water for a long time.
Child dose
5 mg chewable tablet Children 6~14 years of age: Chew 5 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg chewable tablet Children 2~5 years of age: Chew 4 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating tablet Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating tablet Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating film Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating film Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg dry syrup Children 6~14 years of age: Administer 5mg of montelukast orally once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg granules - Asthma Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Infants 12 months~under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. 4 mg granules - Allergic rhinitis Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants 6 months~under 2 years of age: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age. ○ How to take the granules (for granule formulations only) The 4 mg granules may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of room-temperature or cooler infant food, breast milk, or soft food such as porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix with infant food, breast milk, or food, or take the entire amount directly. Do not leave this medicine mixed with infant food, breast milk, or food for a long time; discard any remaining portion. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken regardless of mealtimes.

Ingredients

Manufacturer
Gujoo Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of allergic rhinitis symptoms; prevention and maintenance treatment of asthma

  • Asthma
  • allergic rhinitis symptoms
View approved original text

This medication is used to prevent the onset of asthma and to effectively treat asthma over an extended period. It also helps relieve symptoms caused by seasonal and perennial allergic rhinitis. Therefore, it is recommended as an effective treatment option for patients with asthma and allergic rhinitis.

How to take

Adult dose

Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. 10 mg tablet Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily. 10 mg orally disintegrating film Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. ○ How to take the dry syrup (for syrup formulations only) To take, pour 1 sachet of this medicine into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use. After opening, suspend in water and take the entire amount immediately (within 15 minutes). Do not leave this medicine suspended in water for a long time.

Child dose

5 mg chewable tablet Children 6~14 years of age: Chew 5 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg chewable tablet Children 2~5 years of age: Chew 4 mg of montelukast once daily. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating tablet Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating tablet Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg orally disintegrating film Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Take this medicine 1 hour before or 2 hours after a meal. 4 mg orally disintegrating film Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Take this medicine 1 hour before or 2 hours after a meal. 5 mg dry syrup Children 6~14 years of age: Administer 5mg of montelukast orally once daily. Take this medicine 1 hour before or 2 hours after a meal. 4 mg granules - Asthma Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Infants 12 months~under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. 4 mg granules - Allergic rhinitis Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants 6 months~under 2 years of age: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age. ○ How to take the granules (for granule formulations only) The 4 mg granules may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of room-temperature or cooler infant food, breast milk, or soft food such as porridge. Do not open the package until immediately before use. After opening, immediately (within 15 minutes) mix with infant food, breast milk, or food, or take the entire amount directly. Do not leave this medicine mixed with infant food, breast milk, or food for a long time; discard any remaining portion. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but a beverage may be taken immediately after administration. This medicine may be taken regardless of mealtimes.

Precautions

This medication should not be used by patients who are allergic to this drug or its components. Symptoms such as fatigue, headache, abdominal pain, fever, cough, nasal congestion, and rash may occur during the use of this medication, so caution is advised. Particularly, various adverse reactions have been reported in children, adolescents, and adults, and the incidence of adverse reactions has not significantly changed with prolonged administration. This medication is not intended for the treatment of acute asthma attacks; immediate emergency treatment is required in the case of acute symptoms. Asthma patients should always carry a rescue inhaler while taking this medication, and they should avoid the abrupt discontinuation or switching of inhaled corticosteroid preparations. Neuropsychiatric symptoms such as anxiety, depression, hallucinations, and suicidal thoughts may occur during the use of this medication, so if such symptoms arise, immediate consultation with medical personnel is required. Patients with exercise-induced bronchospasm should not rely solely on this medication for treatment and should continue using inhaled beta-agonists as necessary. Patients with hypersensitivity to aspirin should avoid taking aspirin or non-steroidal anti-inflammatory drugs while on this medication, as this medication may not treat aspirin-induced bronchoconstriction. Patients taking this medication may experience rare side effects such as eosinophilia or vasculitis; if respiratory symptoms worsen or a skin rash occurs, immediate medical evaluation is necessary. No specific interaction reports have been made when combined with other medications; however, caution is required when taken with drugs that induce liver metabolism. The safety of this medication during pregnancy is not completely established, hence pregnant individuals should only take it under the supervision of a physician when necessary, and nursing mothers should also exercise caution. It can be used in pediatric and elderly patients, but the safety for infants under 6 months has not been confirmed. In the case of overdose, there is no specific antidote, hence general symptomatic treatment and clinical monitoring are necessary. This medication should be kept out of the reach of children and should not be transferred to another container. During administration, it should be taken consistently as directed by a physician, and if symptoms worsen or unusual symptoms arise, immediate consultation with medical personnel is required.

Side effects

  • Apathy
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • indigestion
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 93 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • anorexia
  • otitis
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • runny nose
  • ear pain
  • gastrointestinal inflammation
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory tract infection
  • wheezing
  • otitis media
  • tonsillitis
  • sinus headache
  • nosebleed
  • increased frequency of bleeding
  • thrombocytopenia
  • hypersensitivity reaction
  • anaphylaxis
  • liver eosinophilic infiltration
  • aggressive behavior
  • restlessness
  • anxiety
  • depression
  • disorientation
  • attention deficit
  • sleep disorder
  • hallucination
  • insomnia
  • memory impairment
  • psychomotor hyperactivity
  • sleepwalking
  • suicidal impulses
  • behavior
  • tics
  • drowsiness
  • sensory disturbances
  • sensory decline
  • convulsive seizures
  • palpitations
  • pulmonary eosinophilia
  • diarrhea
  • vomiting
  • pancreatitis
  • cholestatic hepatitis
  • hepatocellular liver damage
  • mixed-type liver damage
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • urticaria
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • enuresis
  • edema
  • systemic eosinophilia
  • vasculitis rash
  • worsening pulmonary symptoms
  • cardiac complications
  • neuropathy
  • abdominal pain
  • drowsiness
  • thirst
  • headache
  • vomiting
  • psychomotor agitation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container as it can be degraded by air, moisture, or light. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink chewable tablets with a biconvex round shape

Package unit

28 tablets (7 tablets/PTP×4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.